Sykon Capital’s ProPhase Labs PRPH Stock Holding History

Sykon Capital’s Portfolio PRPH Stock Details PRPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-64,478	Closed	-$28.9K	–	108
2025 Q4	$28.9K	Sell	64,478 -2	-0%	-$6	0.01%	118
2025 Q3	$295K	Hold	64,480	–	–	0.1%	91
2025 Q2	$252K	Buy	+64,480	New	+$216K	0.09%	72
2025 Q1	–	Sell	-1,270	Closed	-$9.62K	–	74
2024 Q4	$9.62K	Hold	1,270	–	–	﹤0.01%	64
2024 Q3	$30.7K	Buy	+1,270	New	+$35.8K	0.01%	93

Other funds holding PRPH

CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Sykon Capital's PRPH Position: Q1 2026 in Review

Sykon Capital sold out of ProPhase Labs (PRPH) in Q1 2026, closing a stake of 64,478 shares — an estimated $28.9K sold.

Sykon Capital first reported a position in PRPH in Q3 2024 and held it in 5 quarters. The position peaked at $295K in Q3 2025. 2 funds tracked by Wall St. Rank hold PRPH as of Q1 2026.

Sykon Capital reported no remaining ProPhase Labs position as of Q1 2026 after selling out during the quarter.
Sykon Capital sold 64,478 ProPhase Labs shares in Q1 2026, an estimated $28.9K.
Sykon Capital first reported a position in ProPhase Labs in Q3 2024 and held it in 5 quarters.
Sykon Capital's ProPhase Labs position peaked at $295K in Q3 2025.
2 funds tracked by Wall St. Rank held ProPhase Labs as of Q1 2026.

Based on Sykon Capital's 13F filing for Q1 2026, filed 22 Apr 2026.